The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Differential overall survival (OS) results in RECORD-3 study based on three distinct mRCC molecular subgroups classified by BAP1 and/or PBRM1 mutations.
 
James Hsieh
Honoraria - Chugai Pharma
Consulting or Advisory Role - Chugai Pharma; Novartis
Research Funding - Novartis; Pfizer
 
David Chen
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Patricia Wang
No Relationships to Disclose
 
Yingbei Chen
No Relationships to Disclose
 
Mahtab Marker
Employment - Novartis
Stock and Other Ownership Interests - Novartis
Travel, Accommodations, Expenses - Novartis
 
Parul Patel
Employment - Merck (I); Novartis
 
Michael Chevinsky
No Relationships to Disclose
 
Umesh Bhanot
No Relationships to Disclose
 
Patrizia Pinciroli
No Relationships to Disclose
 
Michael F. Berger
Consulting or Advisory Role - Cancer Genetics
 
Emily Cheng
No Relationships to Disclose
 
William Lee
Employment - Helix OpCo LLC
Stock and Other Ownership Interests - Helix OpCo LLC
 
Jennifer J. Knox
Honoraria - Novartis
Research Funding - AstraZeneca; Pfizer
 
Martin Henner Voss
Honoraria - Novartis
Consulting or Advisory Role - Bayer; Calithera Biosciences; GlaxoSmithKline; Natera; Novartis
Research Funding - Bristol-Myers Squibb; Pfizer
Travel, Accommodations, Expenses - Novartis
 
Maurizio Voi
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Robert J. Motzer
Consulting or Advisory Role - Eisai; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb